Tudor Investment Corp’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-25,147
| Closed | -$40K | – | 2094 |
|
|
2024
Q1 | $40K | Hold |
25,147
| – | – | ﹤0.01% | 1391 |
|
|
2023
Q4 | $21.6K | Hold |
25,147
| – | – | ﹤0.01% | 1405 |
|
|
2023
Q3 | $26.9K | Sell |
25,147
-14,806
| -37% | -$15.8K | ﹤0.01% | 1431 |
|
|
2023
Q2 | $103K | Hold |
39,953
| – | – | ﹤0.01% | 1427 |
|
|
2023
Q1 | $163K | Buy |
39,953
+3,765
| +10% | +$15.4K | ﹤0.01% | 1401 |
|
|
2022
Q4 | $182K | Sell |
36,188
-4,199
| -10% | -$21.1K | ﹤0.01% | 1378 |
|
|
2022
Q3 | $528K | Buy |
40,387
+871
| +2% | +$11.4K | 0.01% | 1083 |
|
|
2022
Q2 | $507K | Buy |
+39,516
| New | +$507K | 0.01% | 1073 |
|